
Lixte Biotechnology Holdings LIXT
$ 3.1
-0.32%
Annual report 2025
added 03-31-2026
Lixte Biotechnology Holdings PEG Ratio 2011-2026 | LIXT
Annual PEG Ratio Lixte Biotechnology Holdings
| 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|
| - | 0.0152 | 62.3 | 2.07 | -0.147 | -0.1 | -1.75 | 0.0291 | -0.0484 | -6.29 | -0.128 |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 62.3 | -6.29 | 5.59 |
PEG Ratio of other stocks in the Biotechnology industry
| Issuer | PEG Ratio | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
|
Acorda Therapeutics
ACOR
|
-0.000047 | - | -24.86 % | $ 820 K | ||
|
Adverum Biotechnologies
ADVM
|
-0.00407 | - | - | $ 86.2 M | ||
|
MorphoSys AG
MOR
|
-0.169 | - | 2.43 % | $ 254 M | ||
|
Alterity Therapeutics Limited
ATHE
|
-0.0509 | $ 3.85 | 3.22 % | $ 9.26 B | ||
|
Akouos
AKUS
|
0.105 | - | 0.23 % | $ 488 M | ||
|
Alnylam Pharmaceuticals
ALNY
|
-0.955 | $ 327.75 | -1.69 % | $ 42.9 B | ||
|
Applied Molecular Transport
AMTI
|
0.133 | - | - | $ 10.1 M | ||
|
I-Mab
IMAB
|
-0.75 | - | - | $ 866 M | ||
|
AlloVir
ALVR
|
0.1 | - | 4.14 % | $ 49.1 M | ||
|
Alexion Pharmaceuticals, Inc.
ALXN
|
-0.747 | - | - | $ 40.3 B | ||
|
Genfit SA
GNFT
|
-0.0281 | - | 2.54 % | $ 160 B | ||
|
Aligos Therapeutics
ALGS
|
0.0282 | $ 7.65 | 3.1 % | $ 75.6 M | ||
|
Allakos
ALLK
|
0.664 | - | - | $ 28.6 M | ||
|
Burford Capital Limited
BUR
|
-0.568 | $ 4.68 | -0.95 % | $ 756 M | ||
|
Ayala Pharmaceuticals
AYLA
|
0.0783 | - | - | $ 7.46 M | ||
|
Cabaletta Bio
CABA
|
-0.01 | $ 3.44 | 1.03 % | $ 346 M | ||
|
EyeGate Pharmaceuticals, Inc.
EYEG
|
0.254 | - | -1.52 % | $ 24.7 M | ||
|
Midatech Pharma plc
MTP
|
-0.0114 | - | -18.52 % | $ 27.3 M | ||
|
Applied Therapeutics
APLT
|
0.243 | - | - | $ 8.42 M | ||
|
Aptinyx
APTX
|
-0.0809 | - | -39.0 % | $ 4.57 M | ||
|
Aravive
ARAV
|
0.0342 | - | -13.39 % | $ 1.45 M | ||
|
Brainstorm Cell Therapeutics
BCLI
|
-0.00304 | - | -2.5 % | $ 5.88 M | ||
|
Amphastar Pharmaceuticals
AMPH
|
0.154 | $ 21.62 | -0.28 % | $ 1.01 B | ||
|
CymaBay Therapeutics
CBAY
|
-24.1 | - | - | $ 3.45 B | ||
|
BioNTech SE
BNTX
|
-12.8 | $ 99.29 | -0.18 % | $ 27.2 B | ||
|
Институт стволовых клеток человека
ISKJ
|
-2.8 | - | - | - | ||
|
Advaxis
ADXS
|
-0.000022 | - | -9.65 % | $ 45.9 M | ||
|
Aeterna Zentaris
AEZS
|
0.0493 | - | 5.93 % | $ 314 M | ||
|
Can-Fite BioPharma Ltd.
CANF
|
-0.000013 | $ 3.1 | -4.32 % | $ 5.1 M | ||
|
AgeX Therapeutics
AGE
|
-0.51 | - | -10.17 % | $ 12.2 K | ||
|
ContraFect Corporation
CFRX
|
-0.000085 | - | -5.16 % | $ 5.39 M | ||
|
Aeglea BioTherapeutics
AGLE
|
-0.0134 | - | - | $ 1.01 B | ||
|
Akebia Therapeutics
AKBA
|
1.02 | $ 1.41 | -9.03 % | $ 363 M | ||
|
Galectin Therapeutics
GALT
|
0.235 | $ 2.36 | -7.81 % | $ 151 M | ||
|
Applied Genetic Technologies Corporation
AGTC
|
0.00894 | - | - | $ 26.5 M | ||
|
Aquestive Therapeutics
AQST
|
-0.64 | $ 4.18 | -1.5 % | $ 447 M | ||
|
Arcutis Biotherapeutics
ARQT
|
0.0316 | $ 24.23 | -1.42 % | $ 3.08 B | ||
|
AIkido Pharma
AIKI
|
-0.000778 | - | 1.93 % | $ 17.4 M | ||
|
BioDelivery Sciences International
BDSI
|
0.69 | - | -4.8 % | $ 255 M | ||
|
Grifols, S.A.
GRFS
|
-0.077 | $ 8.68 | -0.12 % | $ 6.83 B | ||
|
Autolus Therapeutics plc
AUTL
|
0.0594 | $ 1.48 | -0.67 % | $ 394 M | ||
|
Aptose Biosciences
APTO
|
-0.000164 | - | -45.71 % | $ 1.2 M | ||
|
BeiGene, Ltd.
BGNE
|
9.68 | - | 0.49 % | $ 251 B | ||
|
Checkpoint Therapeutics
CKPT
|
-0.00928 | - | - | $ 169 M | ||
|
Caladrius Biosciences
CLBS
|
-0.00197 | - | -16.75 % | $ 25.8 M | ||
|
AVROBIO
AVRO
|
0.068 | - | 1083.1 % | $ 745 M | ||
|
Clearside Biomedical
CLSD
|
-0.00335 | - | - | $ 25.3 M | ||
|
Celldex Therapeutics
CLDX
|
1.27 | $ 33.44 | -1.27 % | $ 2.22 B | ||
|
bluebird bio
BLUE
|
0.0148 | - | - | $ 546 M |